Gonadotrophin-releasing hormone analogues for pain associated with endometriosis
reference-entry
OA: closed
CC0
⤵ 91 in-corpus citations
AI-generated summary
This protocol outlines a Cochrane Review to assess the efficacy and safety of gonadotrophin-releasing hormone analogues for treating endometriosis-associated pain.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To determine the effectiveness and safety of GnRHas in the treatment of the painful symptoms associated with endometriosis.
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (17)
- 7 Endometriosis and pelvic pain via openalex
- Chronic Pelvic Pain: Prevalence, Health-Related Quality of Life, and Economic Correlates via openalex
- Endometriosis and Infertility via openalex
- Endometriosis: the pathophysiology as an estrogen-dependent disease via openalex
- Experimental Endometriosis via openalex
- GnRH analogues in the treatment of endometriosis — rationale and efficacy via openalex
- Gonadotrophin-releasing hormone analogues for pain associated with endometriosis via openalex
- Laparoscopic surgery for pelvic pain associated with endometriosis via openalex
- Modern Approaches to Endometriosis via openalex
- New aspects of pathogenesis of endometriosis via openalex
- Oral contraceptives for pain associated with endometriosis via openalex
- Progestagens and anti-progestagens for pain associated with endometriosis via openalex
- Progestagens and anti-progestagens for pain associated with endometriosis via openalex
- W1598602811 via openalex
- W6647043730 via openalex
- W6660816686 via openalex
- W6793255116 via openalex
Cited by (50)
- LONG-TERM OUTCOMES OF PHARMACOLOGICAL VERSUS SURGICAL TREATMENT IN WOMEN WITH ENDOMETRIOSIS: IMPACT ON RECURRENCE AND QUALITY OF LIFE — A REVIEW ARTICLE 2026
- Use of pre-operative GnRH-analogue to predict pain outcome following hysterectomy with or without oophorectomies for chronic pelvic pain 2025
- Safety of current strategies to manage moderate to severe pain in patients with endometriosis 2025
- GnRH analogues and dienogest for second line treatment of endometriosis-associated pain: a systematic review, meta-analysis, and network meta-analysis 2025
- Pathogenetic therapy of endometriosis: Updated data on the use of buserelin acetate (depot form) 2025
- Weighing up GnRH agonist therapy for endometriosis: outcomes and the treatment paradigm 2025
- Hormonal Treatment of Endometriosis: A Narrative Review 2025
- Medical Treatment for Endometriosis 2024
- Pain Management for Women with Endometriosis 2024
- Hormonal Therapies before in vitro fertilization in women with endometriosis: The Minotaur's Labyrinth and the Ariadne's Thread 2024
- The long road of drug development for endometriosis - Pains, gains, and hopes 2024
- Horizons in Endometriosis: Proceedings of the Montreux Reproductive Summit, 14-15 July 2023 2024
- Robotic surgery for deep-infiltrating endometriosis: is it time to take a step forward? 2024
- Neuroimmunology of Endometriosis-Associated Pain and Its Psychological Aspects 2024
- Contraception et endométriose 2024
- How to Protect Fertility Potential in Endometriosis 2024
- Systematic Review and Meta-analysis on the Effect of Adjuvant Gonadotropin-releasing Hormone Agonist (GnRH-a) on Pregnancy Outcomes in Women with Endometriosis Following Conservative Surgery. 2023
- Predictive Value of Serum Vascular Endothelial Growth Factor Level for Postoperative Endometriosis Recurrence in Patients with Ovarian Endometriosis 2023
- A review of phase II and III drugs for the treatment and management of endometriosis 2023
- Efficacy and Safety of Dienogest in the Management of Women with Endometriosis; Systematic Review and Meta-Analysis 2023
- Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- The impact of endometriosis and adenomyosis on the female reproductive system 2022
- Endometriosis care: Women’s health nurse practitioners share perspectives 2022
- Hormonal Therapy in Endometriosis and Adenomyosis: Danazol, Aromatase Inhibitors 2022
- Pathophysiology, diagnosis, and management of endometriosis 2022
- Pelvic and urogenital pain 2022
- Hormonal drugs for the treatment of endometriosis 2022
- Clinical practice guidelines for endometriosis in Japan (The 3rd edition) 2022
- The latest advances in the pharmacological management of endometriosis 2022
- Relugolix combination therapy for endometriosis pain 2022
- Reductions in endometriosis-associated pain among women treated with elagolix are consistent across a range of baseline characteristics reflective of real-world patients 2021
- Role of medical treatment of endometriosis 2021
- Diagnosis and treatment of endometriosis in a hooded capuchin (<i>Sapajus apella</i>) 2021
- The Relationship between Decorin and VEGF in Endometriosis 2021
- A model‐based analysis to guide gonadotropin‐releasing hormone receptor antagonist use for management of endometriosis 2021
- Endometriosis - Recent Advances, New Perspectives and Treatments 2021
- Medical management of endometriosis 2021
- Potential Therapeutic Options and Perspectives for Alleviation of Endometrial Estrogen Dominance and Progesterone Resistance in Endometriosis 2021
- General practitioners and endometriosis: Level of knowledge and the impact of training 2021
- Elevated Levels of CA-125, Estradiol and Cortisol as Prominent Markers to Diagnose Various Stages of Endometriosis 2021
- Endometriosis and other causes of pelvic pain in perspective 2021
- An assessment of the efficacy and safety of dydrogesterone in women with ovarian endometrioma: An open‐label multicenter clinical study 2021
- BAG2-Mediated Inhibition of CHIP Expression and Overexpression of MDM2 Contribute to the Initiation of Endometriosis by Modulating Estrogen Receptor Status 2021
- The effectiveness of therapy for endometriosis-associated pelvic pain resistant to surgical treatment 2021
- POSSIBILITIES OF PERSONIFIED TREATMENT TACTICS IN PATIENTS WITH PROLIFERATIVE DISEASES OF THE GENITALS AND CHRONIC PELVIC PAIN 2021
- Treatment of endometriosis: a review with comparison of 8 guidelines 2021
- Endometriosis Pain Management: a Review 2020
- Pharmacological Treatment of Chronic Pelvic Pain 2020
- Adolesan Endometriozis 2020
- Endometriosis Treatment 2020
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK